A Laboratory Study of Behavior and Performance Among People Who Vape Nicotine and/or Smoke Cigarettes - Schizophrenia Supplement
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 50
Healthy Volunteers: f
View:
• 6+ months of daily/near-daily nicotine vaping or cigarette smoking
• 200+ ng/mL cotinine on a commercially-available quick screen
• stable antipsychotic medication dose (no changes in past 6 months).
Locations
United States
New York
University at Buffalo
RECRUITING
Buffalo
Contact Information
Primary
Larry Hawk, PhD
lhawk@buffalo.edu
716-645-0192
Time Frame
Start Date: 2025-02-15
Estimated Completion Date: 2027-04-01
Participants
Target number of participants: 64
Treatments
Other: Daily use of ENDS
Participants who use nicotine-containing ENDS daily or near-daily but who do NOT smoke combustible cigarettes daily or near-daily.
Other: Daily use of combustible cigarettes
Participants who smoke combustible cigarettes daily or near-daily but do NOT use nicotine-containing ENDS daily or near-daily.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), Roswell Park Cancer Institute
Leads: State University of New York at Buffalo